FDA 483 - Molecular Therapeutics LLC - September 10, 2025

An FDA inspection of Molecular Therapeutics LLC in Athens, GA, a manufacturer, revealed significant deficiencies in their quality system. The firm failed to adequately establish procedures for corrective and preventive actions, quality audits, and management review. These observations indicate a fundamental lack of documented processes essential for maintaining product quality and regulatory compliance.